Discovery of 1-[1-(1-Methylcyclooctyl)-4-piperidinyl]-2-[(3R)-3-piperidinyl]-1H-benzimidazole: Integrated Drug-Design and Structure–Activity Relationships for Orally Potent, Metabolically Stable and Potential-Risk Reduced Novel Non-Peptide Nociceptin/Orphanin FQ Receptor Agonist as Antianxiety Drug
Shigeo Hayashi, Akiko Hirao, Hiroshi Nakamura, Kenzo Yamamura, Kunihiko Mizuno, Hiroyo YamashitaVolume:
74
Year:
2009
Language:
english
Pages:
13
DOI:
10.1111/j.1747-0285.2009.00872.x
File:
PDF, 477 KB
english, 2009